NO20061791L - Polymorf form av 3-fenylsulfonyl-8-piperazin-1-yl-kinolin - Google Patents
Polymorf form av 3-fenylsulfonyl-8-piperazin-1-yl-kinolinInfo
- Publication number
- NO20061791L NO20061791L NO20061791A NO20061791A NO20061791L NO 20061791 L NO20061791 L NO 20061791L NO 20061791 A NO20061791 A NO 20061791A NO 20061791 A NO20061791 A NO 20061791A NO 20061791 L NO20061791 L NO 20061791L
- Authority
- NO
- Norway
- Prior art keywords
- phenylsulfonyl
- piperazin
- quinoline
- polymorphic form
- cns
- Prior art date
Links
- JJZFWROHYSMCMU-UHFFFAOYSA-N 3-(benzenesulfonyl)-8-piperazin-1-ylquinoline Chemical compound C=1N=C2C(N3CCNCC3)=CC=CC2=CC=1S(=O)(=O)C1=CC=CC=C1 JJZFWROHYSMCMU-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0322629.7A GB0322629D0 (en) | 2003-09-26 | 2003-09-26 | Novel compound |
| PCT/EP2004/010843 WO2005040124A1 (fr) | 2003-09-26 | 2004-09-23 | Nouveau compose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20061791L true NO20061791L (no) | 2006-04-24 |
Family
ID=29286934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20061791A NO20061791L (no) | 2003-09-26 | 2006-04-24 | Polymorf form av 3-fenylsulfonyl-8-piperazin-1-yl-kinolin |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20070032504A1 (fr) |
| EP (1) | EP1667975B1 (fr) |
| JP (1) | JP2007506702A (fr) |
| CN (1) | CN1856471A (fr) |
| AU (1) | AU2004283805A1 (fr) |
| BR (1) | BRPI0414678A (fr) |
| CA (1) | CA2540022A1 (fr) |
| CO (1) | CO5680402A2 (fr) |
| DE (1) | DE602004010410T2 (fr) |
| DK (1) | DK1667975T3 (fr) |
| ES (1) | ES2297465T3 (fr) |
| GB (1) | GB0322629D0 (fr) |
| HR (1) | HRP20080055T3 (fr) |
| IL (1) | IL174213A0 (fr) |
| IS (1) | IS8399A (fr) |
| MA (1) | MA28093A1 (fr) |
| MX (1) | MXPA06003375A (fr) |
| NO (1) | NO20061791L (fr) |
| PL (1) | PL1667975T3 (fr) |
| PT (1) | PT1667975E (fr) |
| RU (1) | RU2355681C2 (fr) |
| WO (1) | WO2005040124A1 (fr) |
| ZA (1) | ZA200601453B (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2386828T3 (es) * | 2002-03-27 | 2012-08-31 | Glaxo Group Limited | Derivados de quinolina y su uso como ligandos 5-HT6 |
| US8754238B2 (en) | 2003-07-22 | 2014-06-17 | Arena Pharmaceuticals, Inc. | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| PT1663958E (pt) | 2003-09-18 | 2015-06-01 | Virobay Inc | Compostos contendo haloalquilo como inibidores de protease de cisteína |
| MX2007014929A (es) | 2005-06-02 | 2008-02-15 | Hoffmann La Roche | 3-metansulfonilquinolinas como mejoradores de gaba-b. |
| GB0519758D0 (en) * | 2005-09-28 | 2005-11-09 | Glaxo Group Ltd | Novel process |
| WO2008113818A1 (fr) * | 2007-03-21 | 2008-09-25 | Glaxo Group Limited | Utilisation de composés pour le traitement de la douleur et du syndrome du côlon irritable |
| US9084742B2 (en) | 2007-12-12 | 2015-07-21 | Axovant Sciences Ltd. | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-Quinoline |
| US20110021538A1 (en) | 2008-04-02 | 2011-01-27 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| WO2010062321A1 (fr) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Procédés utiles pour la préparation de 1-[3-(4-bromo-2-méthyl-2h-pyrazol-3-yl)-4-méthoxy-phényl]-3-(2,4-difluoro‑phényl)-urée, et formes cristallines associées |
| RU2017145976A (ru) | 2015-06-12 | 2019-07-15 | Аксовант Сайенсиз Гмбх | Производные диарил- и арилгетероарилмочевины, применимые для профилактики и лечения нарушения поведения во время REM-фазы сна |
| TW201720439A (zh) | 2015-07-15 | 2017-06-16 | Axovant Sciences Gmbh | 用於預防及治療與神經退化性疾病相關的幻覺之作為５－ｈｔ２ａ血清素受體的二芳基及芳基雜芳基脲衍生物 |
| WO2017202206A1 (fr) * | 2016-05-27 | 2017-11-30 | 深圳市塔吉瑞生物医药有限公司 | Composé quinoléine substitué et composition pharmaceutique correspondante |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9818916D0 (en) * | 1998-08-28 | 1998-10-21 | Smithkline Beecham Plc | Use |
| ES2386828T3 (es) * | 2002-03-27 | 2012-08-31 | Glaxo Group Limited | Derivados de quinolina y su uso como ligandos 5-HT6 |
| GB0321473D0 (en) * | 2003-09-12 | 2003-10-15 | Glaxo Group Ltd | Novel compounds |
-
2003
- 2003-09-26 PT PT04765655T patent/PT1667975E/pt unknown
- 2003-09-26 GB GBGB0322629.7A patent/GB0322629D0/en not_active Ceased
-
2004
- 2004-09-23 DK DK04765655T patent/DK1667975T3/da active
- 2004-09-23 BR BRPI0414678-6A patent/BRPI0414678A/pt not_active IP Right Cessation
- 2004-09-23 CN CNA2004800275278A patent/CN1856471A/zh active Pending
- 2004-09-23 ES ES04765655T patent/ES2297465T3/es not_active Expired - Lifetime
- 2004-09-23 AU AU2004283805A patent/AU2004283805A1/en not_active Abandoned
- 2004-09-23 JP JP2006527373A patent/JP2007506702A/ja not_active Withdrawn
- 2004-09-23 DE DE602004010410T patent/DE602004010410T2/de not_active Expired - Fee Related
- 2004-09-23 PL PL04765655T patent/PL1667975T3/pl unknown
- 2004-09-23 CA CA002540022A patent/CA2540022A1/fr not_active Abandoned
- 2004-09-23 HR HR20080055T patent/HRP20080055T3/xx unknown
- 2004-09-23 RU RU2006114024/04A patent/RU2355681C2/ru active
- 2004-09-23 MX MXPA06003375A patent/MXPA06003375A/es active IP Right Grant
- 2004-09-23 WO PCT/EP2004/010843 patent/WO2005040124A1/fr not_active Ceased
- 2004-09-23 US US10/572,670 patent/US20070032504A1/en not_active Abandoned
- 2004-09-23 EP EP04765655A patent/EP1667975B1/fr not_active Expired - Lifetime
-
2006
- 2006-02-20 ZA ZA200601453A patent/ZA200601453B/en unknown
- 2006-03-09 IL IL174213A patent/IL174213A0/en unknown
- 2006-03-27 CO CO06030123A patent/CO5680402A2/es not_active Application Discontinuation
- 2006-04-05 IS IS8399A patent/IS8399A/is unknown
- 2006-04-13 MA MA28933A patent/MA28093A1/fr unknown
- 2006-04-24 NO NO20061791A patent/NO20061791L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MA28093A1 (fr) | 2006-08-01 |
| HRP20080055T3 (en) | 2008-02-29 |
| HK1094190A1 (en) | 2007-03-23 |
| DE602004010410D1 (en) | 2008-01-10 |
| DE602004010410T2 (de) | 2008-10-16 |
| ZA200601453B (en) | 2007-04-25 |
| IS8399A (is) | 2006-04-05 |
| CO5680402A2 (es) | 2006-09-29 |
| RU2355681C2 (ru) | 2009-05-20 |
| EP1667975B1 (fr) | 2007-11-28 |
| PL1667975T3 (pl) | 2008-04-30 |
| CA2540022A1 (fr) | 2005-05-06 |
| ES2297465T3 (es) | 2008-05-01 |
| GB0322629D0 (en) | 2003-10-29 |
| CN1856471A (zh) | 2006-11-01 |
| MXPA06003375A (es) | 2006-06-08 |
| WO2005040124A1 (fr) | 2005-05-06 |
| DK1667975T3 (da) | 2008-04-14 |
| EP1667975A1 (fr) | 2006-06-14 |
| JP2007506702A (ja) | 2007-03-22 |
| BRPI0414678A (pt) | 2006-11-28 |
| AU2004283805A1 (en) | 2005-05-06 |
| PT1667975E (pt) | 2008-02-29 |
| RU2006114024A (ru) | 2007-11-10 |
| IL174213A0 (en) | 2006-08-01 |
| US20070032504A1 (en) | 2007-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
| DK1648905T3 (da) | Inhibitorer for thienopyridin- og furopyridinkinase | |
| EA200501274A1 (ru) | Пиразолы и способы их получения и применения | |
| TW200504015A (en) | Indazole, benzisoxazole, and benzisothiazole kinase inhibitors | |
| NO20073140L (no) | Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser | |
| EA200700851A1 (ru) | Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения | |
| TW200510317A (en) | Caspase inhibitors and uses thereof | |
| WO2006050109A3 (fr) | Nouveaux inhibiteurs de kinase | |
| TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
| NO20006645L (no) | Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme | |
| SE0301368D0 (sv) | Chemical compounds | |
| NO20061791L (no) | Polymorf form av 3-fenylsulfonyl-8-piperazin-1-yl-kinolin | |
| NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
| NO20062256L (no) | Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner | |
| MXPA05009151A (es) | Inhibidores de cinasa heterociclica. | |
| WO2004043379A3 (fr) | Composes chimiques | |
| GB0322510D0 (en) | Novel compounds | |
| SE0300850D0 (sv) | Chemical compounds | |
| HRP20080057T3 (en) | 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof | |
| DE60329326D1 (de) | Tace inhibitoren | |
| ATE359283T1 (de) | Substituierte pyrazinonverbindungen zur behandlung von entzündungen | |
| SE0200844D0 (sv) | Chemical compounds | |
| SE0200843D0 (sv) | Chemical compounds | |
| DE602004006118D1 (de) | 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER | |
| ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |